BIOMAT Database Logo BIOMAT Database Logo

Cryptogenic chronic liver disease and serum or liver hepatitis B virus markers. Their possible correlations and etiologic significance. 1988

G Diodati, and P Pontisso, and P Bonetti, and D Stenico, and F Noventa, and A Alberti, and G Realdi
Department of Clinical Medicine, 2nd Medical Clinic, Padua Medical University, Italy.

In an attempt to evaluate a possible correlation between cryptogenic chronic liver disease and a present or past hepatitis B virus (HBV) infection, we studied 17 patients with hepatitis B surface antigen (HBsAg)-negative, nonalcoholic chronic liver disease; 9 of them were positive for serum HBsAg detected by a solid-phase enzyme immunoassay with monoclonal antibody (M-EIA) and 8 were negative for the same marker. Liver hepatitis B core antigen (HBcAg), studied by an indirect immunofluorescence technique, was present in 55.5% of the patients positive for serum HBsAg by M-EIA. In the same group of patients, liver HBV-DNA was found in 66.6% of the patients. On the other hand, only 1 patient without serum positivity for HBsAg by M-EIA was positive for liver HBcAg and HBV-DNA. None of our patients showed serum positivity for HBV-DNA sequences. We conclude that HBV infection may be a possible cause of cryptogenic chronic liver disease; this HBV-related, HBsAg-negative chronic liver disease seems to have no viral replication or undetectable levels of HBV-DNA in serum. HBsAg, detected by a monoclonal assay, seems to be a suitable marker to identify this subgroup of patients with HBsAg-negative chronic liver disease.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D004279 DNA, Viral Deoxyribonucleic acid that makes up the genetic material of viruses. Viral DNA
D005455 Fluorescent Antibody Technique Test for tissue antigen using either a direct method, by conjugation of antibody with fluorescent dye (FLUORESCENT ANTIBODY TECHNIQUE, DIRECT) or an indirect method, by formation of antigen-antibody complex which is then labeled with fluorescein-conjugated anti-immunoglobulin antibody (FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT). The tissue is then examined by fluorescence microscopy. Antinuclear Antibody Test, Fluorescent,Coon's Technique,Fluorescent Antinuclear Antibody Test,Fluorescent Protein Tracing,Immunofluorescence Technique,Coon's Technic,Fluorescent Antibody Technic,Immunofluorescence,Immunofluorescence Technic,Antibody Technic, Fluorescent,Antibody Technics, Fluorescent,Antibody Technique, Fluorescent,Antibody Techniques, Fluorescent,Coon Technic,Coon Technique,Coons Technic,Coons Technique,Fluorescent Antibody Technics,Fluorescent Antibody Techniques,Fluorescent Protein Tracings,Immunofluorescence Technics,Immunofluorescence Techniques,Protein Tracing, Fluorescent,Protein Tracings, Fluorescent,Technic, Coon's,Technic, Fluorescent Antibody,Technic, Immunofluorescence,Technics, Fluorescent Antibody,Technics, Immunofluorescence,Technique, Coon's,Technique, Fluorescent Antibody,Technique, Immunofluorescence,Techniques, Fluorescent Antibody,Techniques, Immunofluorescence,Tracing, Fluorescent Protein,Tracings, Fluorescent Protein
D006509 Hepatitis B INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Hepatitis B Virus Infection
D006512 Hepatitis B Core Antigens The hepatitis B antigen within the core of the Dane particle, the infectious hepatitis virion. HBcAg,Hepatitis B Core Antigen
D006514 Hepatitis B Surface Antigens Those hepatitis B antigens found on the surface of the Dane particle and on the 20 nm spherical and tubular particles. Several subspecificities of the surface antigen are known. These were formerly called the Australia antigen. Australia Antigen,HBsAg,Hepatitis B Surface Antigen,Antigen, Australia
D006521 Hepatitis, Chronic INFLAMMATION of the LIVER with ongoing hepatocellular injury for 6 months or more, characterized by NECROSIS of HEPATOCYTES and inflammatory cell (LEUKOCYTES) infiltration. Chronic hepatitis can be caused by viruses, medications, autoimmune diseases, and other unknown factors. Chronic Hepatitis,Cryptogenic Chronic Hepatitis,Hepatitis, Chronic, Cryptogenic,Hepatitis, Chronic Active,Hepatitis, Chronic Persistent,Chronic Active Hepatitis,Chronic Hepatitis, Cryptogenic,Chronic Persistent Hepatitides,Chronic Persistent Hepatitis,Hepatitis, Cryptogenic Chronic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D001706 Biopsy Removal and pathologic examination of specimens from the living body. Biopsies

Related Publications

G Diodati, and P Pontisso, and P Bonetti, and D Stenico, and F Noventa, and A Alberti, and G Realdi
[Hepatitis B virus markers and cryptogenic enterocolitis].
January 1983, Gastroenterologie clinique et biologique,
G Diodati, and P Pontisso, and P Bonetti, and D Stenico, and F Noventa, and A Alberti, and G Realdi
Serum markers of hepatitis B virus and anti-delta antibody in chronic liver disease.
December 1985, Quaderni Sclavo di diagnostica clinica e di laboratorio,
G Diodati, and P Pontisso, and P Bonetti, and D Stenico, and F Noventa, and A Alberti, and G Realdi
Etiology and prognosis of cryptogenic liver cirrhosis: possible contribution of hepatitis B virus.
January 1997, Journal of medicine,
G Diodati, and P Pontisso, and P Bonetti, and D Stenico, and F Noventa, and A Alberti, and G Realdi
[Tissue markers of hepatitis B virus: useful indicators in the etiologic diagnosis of chronic alcoholic and non-alcoholic liver disease].
September 1986, Recenti progressi in medicina,
G Diodati, and P Pontisso, and P Bonetti, and D Stenico, and F Noventa, and A Alberti, and G Realdi
Antibody to hepatitis C virus in cryptogenic chronic liver disease.
November 1991, Journal of medical virology,
G Diodati, and P Pontisso, and P Bonetti, and D Stenico, and F Noventa, and A Alberti, and G Realdi
[Serum markers of hepatitis B virus in chronic active hepatitis].
May 1983, Revista medica de Chile,
G Diodati, and P Pontisso, and P Bonetti, and D Stenico, and F Noventa, and A Alberti, and G Realdi
Cryptogenic chronic liver disease and hepatitis C virus infection in children.
May 1992, Journal of hepatology,
G Diodati, and P Pontisso, and P Bonetti, and D Stenico, and F Noventa, and A Alberti, and G Realdi
Are hepatitis G virus and TT virus involved in cryptogenic chronic liver disease?
January 2002, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver,
G Diodati, and P Pontisso, and P Bonetti, and D Stenico, and F Noventa, and A Alberti, and G Realdi
[Serum markers of B virus in chronic active hepatitis].
January 1981, Revista de gastroenterologia de Mexico,
G Diodati, and P Pontisso, and P Bonetti, and D Stenico, and F Noventa, and A Alberti, and G Realdi
[Markers of hepatitis B virus in chronic liver diseases].
January 1987, Terapevticheskii arkhiv,
Copied contents to your clipboard!